2017 Keynotes

Larry Renfro
Vice Chairman, UnitedHealth Group
Chief Executive Officer, Optum


Larry Renfro is vice chairman of UnitedHealth Group and chief executive officer of Optum. As vice chairman, Renfro oversees enterprise strategic relationships, key client relationships and company-wide growth initiatives. As CEO of Optum, he leads UnitedHealth Group’s information and technology-enabled health services business.

Since joining UnitedHealth Group in 2009, Renfro has focused on growth and development as a member of the office of the CEO. He previously served as chief executive officer of the company’s Public and Senior Markets Group.
Renfro was formerly a senior executive officer at Fidelity Investments and a member of the Fidelity Executive Committee. He was president and chief executive officer of AARP Services, Inc. before he rejoined Fidelity in 2008. Renfro has also held senior executive positions at NewRiver, Inc., State Street Bank & Trust, and Allmerica Financial. 


Dr. Betsy Nabel
Presiden
t, Brigham Health

Betsy Nabel has served as president of Harvard-affiliated Brigham Health, an academic medical system which includes Brigham and Women’s Hospital, since 2010.  A cardiologist and distinguished biomedical researcher, Nabel is Professor of Medicine at Harvard Medical School.

Nabel brings a unique perspective to health care based on her experience as a physician, research scientist, academic medicine leader, and wellness advocate.  At Brigham Health, Nabel is leading development of a new model of academic medicine devoted to maintaining and restoring health through leadership in scientific discovery, education, and compassionate care. Initiatives include a new translational research and clinical facility, leading-edge care redesign, and a $1.5 billion campaign to advance life-giving breakthroughs.

Building on her lifelong commitment to improving health through science, in 2015 Nabel was appointed chief health and medical advisor to the National Football League. In this newly created advisory role, Nabel provides strategic input to the NFL’s medical, health and scientific efforts; participates as an ex-officio member on each of the NFL’s medical advisory committees; and identifies areas for the NFL to enhance player safety, care and treatment.

Nabel has a long record of advocacy for health and broadening access to care. As director of the National Heart, Lung, and Blood Institute from 2005-2009, Nabel leveraged the $3 billion research portfolio to establish pioneering scientific programs in genomics, stem cells, and translational research. One of her signature advocacy efforts was the Red Dress Heart Truth campaign, which raises heart awareness in women through unprecedented industry partnerships.

An accomplished physician-scientist, Nabel’s work on the molecular genetics of cardiovascular diseases has produced17 patents and more than 250 scientific publications. Nabel’s scientific contributions in cardiovascular gene transfer have developed molecular and cellular techniques, delineated that the pathophysiology of atherosclerosis and clarified the processes of cell division and growth of vascular smooth muscle cells in blood vessels. Her studies on Hutchinson-Gilford Progeria Syndrome have characterized the vascular smooth muscle cell defect leading to premature heart attack and stroke.

Nabel has been named one of the nation’s top leaders in medicine by Modern Healthcare and Becker’s Hospital Review, and one of Boston’s 50 most powerful people by Boston Magazine. Her honors include the Distinguished Bostonian Award from the Greater Boston Chamber of Commerce, the Kober Medal from the Association of American Physicians, the Champion in Health Care award from the Boston Business Journal, the Willem Einthoven Award from Leiden University in the Netherlands, the Amgen-Scientific Achievement Award, two Distinguished Achievement Awards and the Eugene Braunwald Academic Mentorship Award from the American Heart Association, and six honorary doctorates.

Her colleagues have elected her to the American Academy of the Arts and Sciences, the National Academy of Medicine, the Association of American Physicians, the American Society of Clinical Investigation, and she is a Fellow of the American Association for the Advancement of Science. Nabel serves on the boards of Medtronic, Moderna Therapeutics, the Broad Institute, Howard Hughes Medical Institute, Partners In Health, Ariadne Labs and the Boys & Girls Club of Boston, and previously served on the editorial boards for the New England Journal of Medicine and Science Translational Medicine as well as editor-in-chief of Scientific American Medicine.

A native of St. Paul, Minnesota, Nabel attended Weill Cornell Medical College and completed her internal medicine and cardiology training at Brigham and Women’s Hospital. She and her husband Gary, who is the chief scientific officer for Sanofi, have three children, all of whom are pursuing careers in medicine.